Htike, Zin Z <br/><br/>
Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis.  [electronic resource] 

 -  Diabetes, obesity & metabolism  04 2017 
 - 524-536 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/dom.12849  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Glucose--drug effects<br/>Diabetes Mellitus, Type 2--blood<br/>Drug Administration Schedule<br/>Exenatide<br/>Female<br/>Glucagon-Like Peptide 1--administration & dosage<br/>Glucagon-Like Peptides--administration & dosage<br/>Glycated Hemoglobin--drug effects<br/>Humans<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--administration & dosage<br/>Immunoglobulin Fc Fragments--administration & dosage<br/>Incretins--administration & dosage<br/>Liraglutide--administration & dosage<br/>Male<br/>Middle Aged<br/>Peptides--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Recombinant Fusion Proteins--administration & dosage<br/>Treatment Outcome<br/>Venoms--administration & dosage<br/>Glucagon-Like Peptide-1 Receptor Agonists